瘤粘附性基托衍生多免疫激动剂释放出强大而持久的抗癌免疫力
Huilan He1,2, Liang Liu1,2,3, Yun Zheng1,2
1College of Pharmaceutical Sciences and State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 25, 2025
概括
一种新型的素结合免疫激动体结构 (TACTIC) 通过改善瘤微环境和刺激免疫细胞来增强抗瘤免疫力. 这种方法有望改善癌症免疫治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 癌症免疫学 癌症免疫学
- 药物输送系统 药物输送系统
背景情况:
- 有效的癌症免疫疗法依赖于调节瘤微环境.
- 目前的免疫激动剂面临着诸如保留不良和生物相容性等挑战,限制了有效性.
- 对传统治疗反应有限的瘤需要新的免疫调节策略.
研究的目的:
- 开发和评估一种瘤粘附性酸盐结合免疫激动剂构造 (TACTIC).
- 评估TACTIC的生物相容性,免疫刺激作用和增强瘤免疫性的能力.
- 研究TACTIC在重塑瘤微环境和改善癌症免疫治疗方面的潜力.
主要方法:
- 开发一种与素结合的免疫激动剂结构 (TACTIC).
- 在实验室中评估TACTIC的生物相容性和免疫刺激作用.
- 在放射治疗后的小鼠癌症模型中评估TACTIC的疗效,包括机理学研究.
- 系统性免疫反应和记忆效应的分析.
主要成果:
- 塔克特表现出良好的生物相容性和强大的免疫刺激作用.
- 该结构增强了瘤细胞的免疫性,并刺激了前炎性反应.
- TACTIC有效地重塑了被辐射的瘤微环境,并在体内改善了瘤控制.
- 引起了带有记忆效应的全身免疫反应.
结论:
- 在癌症免疫治疗中,TACTIC显示出作为宏分子免疫辅助剂的巨大潜力.
- 该结构有效地克服了当前免疫激动剂的局限性.
- TACTIC为创新的癌症治疗提供了一个有前途的策略,特别是放射治疗后.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462


